Skip to content
Roboearth – Lifestyle
Author:
Business Wire
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
June 25, 2026
Social Media Victims Law Center Lawsuit Claims Snap’s Design Enabled Predator to Find, Groom, and Sexually Assault 12‑Year‑Old Missouri Girl
June 25, 2026
MEFA Responds to Federal Student Loan Restrictions with Expanded, Competitive State-Based Options
June 25, 2026
U.S. Conference of Mayors Adopts Landmark Transit Modernization Resolution, Sponsored by West Sacramento, CA Mayor Martha Guerrero
June 25, 2026
Court Case Would Bring Vegan Meals to College Students in Peru
June 25, 2026
Overture Life Launches Global ICSI.A Center of Excellence Program, Bringing the World’s First Automated ICSI into Clinical Use Across Five Leading Global Fertility Centers
June 25, 2026
Unmanned Vehicle Technologies Supports Kansas City Airspace Readiness for FIFA World Cup 2026 With Layered Counter-UAS Initiative
June 25, 2026
Plan B Highlights the Voice of Republican Voters: 72 Percent Say Policymakers Should Protect Access to Emergency Contraception
June 25, 2026
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
June 25, 2026
Social Media Victims Law Center Lawsuit Claims Snap’s Design Enabled Predator to Find, Groom, and Sexually Assault 12‑Year‑Old Missouri Girl
June 25, 2026
←
Previous Page
1
…
21
22
23
24
25
…
3,194
Next Page
→